CML develops when hematopoietic stem cells acquire a reciprocal translocation between chromosomes 9 and 22 that creates a fusion between the breakpoint cluster region (BCR) on chromosome 22 and the Abelson (ABL) tyrosine kinase on chromosome 9. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.